The novel therapy of the medication represents a major development in the management of the condition. Distinct from existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – leading to https://tirzepatidepeptide059857.diowebhost.com/97236034/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment